ANVS - Annovis Bio files for $250M mixed shelf
2024-02-01 16:10:53 ET
More on Annovis Bio
- Annovis And Alzheimer's Disease: The Best-Laid Plans
- Stocks To Watch: Eyes On Chipmakers, Tesla, Netflix And BrightSpring IPO
- Annovis Bio: Buntanetap Likely To Disappoint In The Upcoming AD And PD Clinical Trials
- Annovis falls 16% on Phase 3 data delay for Parkinson's drug
- Annovis Bio gains after enrollment update on trial for Alzheimer’s drug